Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.
Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.
复制标题
载脂蛋白 E 和 LRP1 在帕金森病发病机制早期增加。
DOI:
10.1016/j.ajpath.2011.07.021
复制
发表时间:
2011
期刊:
影响因子:
--
通讯作者:
Hoozemans,JeroenJM
中科院分区:
文献类型:
--
作者:
Wilhelmus,MichaMM;Bol,JohnGJM;VanHaastert,EliseS;Rozemuller,AnnemiekeJM;Bu,Guojun;Drukarch,Benjamin;Hoozemans,JeroenJM
Parkinson's disease (PD) is characterized by α-synuclein–containing Lewy bodies (LBs) and loss of melanized neurons in the substantia nigra (SN). Recently, a link between apolipoprotein E (ApoE) expression, α-synuclein aggregation, and neurodegeneration was suggested. Here, we report on ApoE expression appearing in melanized neurons of the SN and in LBs in both PD and incidental LB disease cases. Interestingly, increased expression of the low-density lipoprotein receptor-related protein 1 (the receptor for ApoE) was also observed in incidental LB disease and PD. Our data suggest that alterations in lipoprotein homeostasis/signaling in melanized neurons of the SN are an early event during PD pathogenesis.